Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 13 results found. Search for [ Shailesh Ayyangar ]

Results 1 to 13 of 13
PTI
December 15, 2017



By Dr. Shailesh Ayyangar
August 23, 2016
It's uncommon for anyone living in India to be unfamiliar with non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, lung infections and cancer.


IANS
March 25, 2016
Mallya had first joined in December 1973 as director of Sanofi India Ltd (SIL), then known as Hoechst Pharmaceuticals Ltd. He functioned as the board chairman since December 1983.


Clifford Alvares
March 7, 2015
More than 80 executives had a fun day at work at BT's golf event in Mumbai recently.


Shailesh Ayyangar
March 5, 2015
The reduction in corporate tax rate from 30 per cent to 25 per cent will boost investor confidence and encourage companies to continue the process of job creation and overall growth.


P.B. Jayakumar
March 5, 2015
The US is mounting pressure on India to agree to its terms in pharma IP protection. How long can India resist?


E Kumar Sharma
January 30, 2015
Located in Muppireddipalli on the outskirts of Hyderabad, it will be Sanofi's second plant apart from the one in Frankfurt, Germany.


PB Jayakumar
January 22, 2015
In the past few years, about six drugs were denied patents in India, as the Indian patent system does not allow incremental innovations.


PTI
New Delhi, August 6, 2014
s per the agreement, Sanofi will continue to own its oncology range comprising four brands namely Taxotere, Jevtana, Fludara and Fasturtec, while Emcure will market and distribute these brands through its specialty unit.


E Kumar Sharma
July 15, 2014
\"By issuing a price control order under Para 19 without any consultation with the industry bodies, the NPPA has shocked and disappointed the pharma industry,\" said Shailesh Ayyangar, Managing Director India and Vice-President (South Asia), Sanofi India Limited, one of the companies likely to be affected by this move.  


E. Kumar Sharma
April 18, 2014
Sanofi India has just hired a seasoned professional from the FMCG space, appointing N Rajaram general manager for pharmaceutical operations in India, a position it has created for the first time. Rajaram comes to Sanofi with over two decades of experience with Hindustan Unilever, and thereafter in the telecom industry with Airtel


E. Kumar Sharma
February 26, 2014
The US regulators increased scrutiny of Indian drug exporters is giving the pharmaceutical industry the jitters. Besides becoming more frequent, inspections are also more often unannounced. Adding to Indian drug makers anxiety is the nature and scope of the inspections.


PTI
Mumbai, November 28, 2013
Indian as well as multinational pharmaceutical companies are likely to create more jobs in 2014 on the back of expected double digit growth in the key sector, according to industry experts.


PAGES 1 OF 1